CN114053173A - Formula and preparation process of ganoderma lucidum spore oil skin cream for infants and adults - Google Patents
Formula and preparation process of ganoderma lucidum spore oil skin cream for infants and adults Download PDFInfo
- Publication number
- CN114053173A CN114053173A CN202111395537.9A CN202111395537A CN114053173A CN 114053173 A CN114053173 A CN 114053173A CN 202111395537 A CN202111395537 A CN 202111395537A CN 114053173 A CN114053173 A CN 114053173A
- Authority
- CN
- China
- Prior art keywords
- oil
- parts
- ganoderma lucidum
- lucidum spore
- infants
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 240000008397 Ganoderma lucidum Species 0.000 title claims abstract description 39
- 235000001637 Ganoderma lucidum Nutrition 0.000 title claims abstract description 39
- 239000002884 skin cream Substances 0.000 title claims abstract description 34
- 238000002360 preparation method Methods 0.000 title claims abstract description 19
- 238000009472 formulation Methods 0.000 title description 3
- 239000003921 oil Substances 0.000 claims abstract description 75
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 41
- 235000011187 glycerol Nutrition 0.000 claims abstract description 17
- 235000009024 Ceanothus sanguineus Nutrition 0.000 claims abstract description 16
- 240000003553 Leptospermum scoparium Species 0.000 claims abstract description 16
- 235000015459 Lycium barbarum Nutrition 0.000 claims abstract description 16
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 16
- AJBZENLMTKDAEK-UHFFFAOYSA-N 3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-4,9-diol Chemical compound CC12CCC(O)C(C)(C)C1CCC(C1(C)CC3O)(C)C2CCC1C1C3(C)CCC1C(=C)C AJBZENLMTKDAEK-UHFFFAOYSA-N 0.000 claims abstract description 15
- 235000003880 Calendula Nutrition 0.000 claims abstract description 15
- 235000013871 bee wax Nutrition 0.000 claims abstract description 15
- 239000012166 beeswax Substances 0.000 claims abstract description 15
- 239000000341 volatile oil Substances 0.000 claims abstract description 15
- 244000042037 Malus x micromalus Species 0.000 claims abstract description 10
- 235000018960 Malus x micromalus Nutrition 0.000 claims abstract description 10
- 241000222336 Ganoderma Species 0.000 claims abstract description 9
- 239000002994 raw material Substances 0.000 claims abstract description 9
- 230000005855 radiation Effects 0.000 claims abstract description 8
- 240000001432 Calendula officinalis Species 0.000 claims abstract 5
- 239000011521 glass Substances 0.000 claims description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 9
- 230000001954 sterilising effect Effects 0.000 claims description 9
- 238000004659 sterilization and disinfection Methods 0.000 claims description 9
- 238000003756 stirring Methods 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 238000010438 heat treatment Methods 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 241000220225 Malus Species 0.000 claims description 3
- 238000005507 spraying Methods 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 6
- 206010061218 Inflammation Diseases 0.000 abstract description 5
- 230000004054 inflammatory process Effects 0.000 abstract description 5
- 206010028980 Neoplasm Diseases 0.000 abstract description 4
- 230000003647 oxidation Effects 0.000 abstract description 3
- 238000007254 oxidation reaction Methods 0.000 abstract description 3
- 230000002633 protecting effect Effects 0.000 abstract description 3
- 230000002000 scavenging effect Effects 0.000 abstract description 3
- 206010020751 Hypersensitivity Diseases 0.000 abstract description 2
- 230000032683 aging Effects 0.000 abstract description 2
- 208000026935 allergic disease Diseases 0.000 abstract description 2
- 230000007815 allergy Effects 0.000 abstract description 2
- 230000003712 anti-aging effect Effects 0.000 abstract description 2
- 239000003963 antioxidant agent Substances 0.000 abstract description 2
- 230000003078 antioxidant effect Effects 0.000 abstract description 2
- 201000011510 cancer Diseases 0.000 abstract description 2
- 239000002537 cosmetic Substances 0.000 abstract description 2
- 230000036039 immunity Effects 0.000 abstract description 2
- 230000002401 inhibitory effect Effects 0.000 abstract description 2
- 210000004185 liver Anatomy 0.000 abstract description 2
- 230000004223 radioprotective effect Effects 0.000 abstract description 2
- 230000009759 skin aging Effects 0.000 abstract description 2
- 230000003860 sleep quality Effects 0.000 abstract description 2
- 230000002087 whitening effect Effects 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 23
- 241000132025 Calendula Species 0.000 description 10
- 230000029663 wound healing Effects 0.000 description 6
- 230000003020 moisturizing effect Effects 0.000 description 4
- 229940088597 hormone Drugs 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 239000002674 ointment Substances 0.000 description 3
- 244000134242 Malus prunifolia Species 0.000 description 2
- 235000005087 Malus prunifolia Nutrition 0.000 description 2
- 230000003467 diminishing effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 208000020154 Acnes Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010064503 Excessive skin Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 241000222341 Polyporaceae Species 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Birds (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Emergency Medicine (AREA)
- Pulmonology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention belongs to the field of skin care products, in particular to a formula of ganoderma lucidum spore oil skin cream for infants and adults and a preparation process thereof, wherein the formula comprises the following raw materials of ganoderma lucidum spore oil skin cream for infants and adults; 1490 part of tea tree fruit oil and 2510 parts of tea tree fruit oil; 1790 and 1810 portions of beeswax; 90-110 parts of malus micromalus oil; 190 portions of glycerin and 210 portions of glycerin; 90-110 parts of ganoderma spore oil; 1-3 parts of calendula essential oil; the ganoderma spore oil has the effects of resisting inflammation, relieving pain, improving immunity, resisting oxidation, resisting aging, improving sleep quality, resisting cancer, inhibiting tumor, protecting liver, etc.; the Ganoderma spore oil has effects of improving skin and caring skin, and has antiaging, antioxidant, and radioprotective effects; can be used in cosmetics for caring skin, such as scavenging free radicals, whitening skin, keeping moisture, improving horny layer, refreshing skin, delaying skin aging, removing speckle, resisting inflammation, resisting radiation and resisting allergy.
Description
Technical Field
The invention relates to the field of skin care products, in particular to a formula of ganoderma lucidum spore oil skin cream for infants and adults and a preparation process thereof.
Background
The skin is the largest organ in the human body, is used for isolating and protecting the human body from direct contact with the outside, and can be used for cooling the human body.
Ganoderma lucidum is fungus of Ganoderma of Ganodermataceae, and is important precious Chinese medicine, and Ganoderma lucidum spore oil is effective substance extracted from Ganoderma lucidum, and has effects of resisting oxidation and scavenging free radicals.
The existing skin cream is developed aiming at different skin diseases, only single symptom is often applied, and hormone is added for treating some diseases, so that the existing skin cream can only be used by adults and cannot be used by infants; therefore, the formula and the preparation process of the ganoderma lucidum spore oil skin cream for infants and adults are provided aiming at the problems.
Disclosure of Invention
The invention provides a formula of ganoderma lucidum spore oil skin cream for infants and adults and a preparation process thereof, aiming at making up the defects of the prior art and solving the problems that the existing skin cream is developed aiming at different skin diseases, can only be applied to single symptoms, and only can be used by adults and cannot be used by infants due to the addition of hormones for treating some diseases.
The technical scheme adopted by the invention for solving the technical problems is as follows: the formula of the ganoderma lucidum spore oil skin cream for infants and adults comprises the following raw materials in parts by weight;
1490 portion and 2510 portion of tea tree fruit oil
1790 portion of beeswax and 1810 portion
90-110 parts of malus micromalus oil
Glycerin 190-
90-110 parts of ganoderma lucidum spore oil
1-3 parts of calendula essential oil.
A preparation process of ganoderma spore oil infant adult skin cream is used for preparing the formula of the ganoderma spore oil infant adult skin cream, and comprises the following steps: the preparation process comprises the following steps;
s1: 2500 parts of tea tree fruit oil with the purity of more than 99 percent, 1800 parts of beeswax, 100 parts of malus micromalus oil and 200 parts of glycerol are purchased;
s2: placing 2500 parts of tea tree fruit oil prepared in S1, 1800 parts of beeswax, 100 parts of malus wallichiana oil and 200 parts of glycerol into a sterile container, heating in a water bath at 75-85 ℃ in a water bath, and uniformly stirring and mixing by using a glass rod in the heating and dissolving process;
s3: purchasing 100 parts of ganoderma lucidum spore oil with the purity of more than 99% and 2 parts of calendula essential oil;
s4: standing the mixture stirred and dissolved in the step S2, adding 100 parts of ganoderma lucidum spore oil and 2 parts of calendula essential oil when the temperature of the surface and the temperature of the interior of the mixture reach 60 ℃ through a temperature measuring gun, and fully stirring and uniformly mixing through a glass rod;
s5: and filling the uniformly mixed raw materials into a paste filling machine, keeping the constant temperature at 60 ℃, and filling the paste in an aseptic manner.
Preferably, the tea tree fruit oil, the beeswax, the malus micromalus oil and the glycerin purchased in the step S1 are purchased through an online shopping mode, and an official store is selected for purchase.
Preferably, the sterile container in S2 is sterilized by radiation sterilization and alcohol before use.
Preferably, the ganoderma lucidum spore oil and calendula essential oil purchased in the step S3 are purchased through an online shopping mode, and an official store is selected for purchase.
Preferably, the S4 is performed by continuously stirring with a glass rod and intermittently measuring whether the temperature is reduced to 60 degrees when the temperature is reduced.
Preferably, the finished product after the filling of the S5 is subjected to code spraying after the surface is subjected to alcohol sterilization, and the production date and the shelf life are sprayed.
Preferably, the glass rod in S2 is sterilized by radiation sterilization and alcohol before use and then used.
The invention has the advantages that:
1. the ganoderma lucidum spore oil has the effects of resisting inflammation, easing pain, improving immunity of organisms, resisting oxidation and aging, improving sleep quality, resisting cancer, inhibiting tumors, protecting livers and the like; the Ganoderma spore oil has effects of improving skin and caring skin, and has antiaging, antioxidant, and radioprotective effects; can be used in cosmetics for caring skin, such as scavenging free radicals, whitening skin, keeping moisture, improving horny layer, refreshing skin, delaying skin aging, removing speckle, resisting inflammation, resisting radiation and resisting allergy; the glycerin absorbs moisture, so that the skin is protected from chapping, the moisture can be absorbed from the air, the main effects of moisturizing and moistening the skin are achieved, the skin can be quickly moistened compared with the facial skin, a protective film is formed to lock the moisture of the skin, the skin cell metabolism is promoted, and the skin pigmentation is lightened;
2. the skin cream prepared by the formula has the characteristic of no hormone, so that the skin cream can be used in all age groups, can be used for preparing the skin of the whole body, has the functions of promoting wound healing, diminishing inflammation, resisting bacteria, removing acnes and diminishing swelling for the skin, and can effectively relieve eczema and tinea.
Drawings
In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings used in the description of the embodiments or the prior art will be briefly described below, and it is obvious that the drawings in the following description are only some embodiments of the present invention, and for those skilled in the art, other drawings can be obtained according to these drawings without inventive exercise.
FIG. 1 is a schematic process flow diagram of the present invention.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the drawings in the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
Example 1
An infant skin cream formula of ganoderma lucidum spore oil comprises the following raw materials in parts by weight;
1490 parts of tea tree fruit oil
1790 portions of beeswax
90 parts of Qiongya plum-leaf crab oil
190 portions of glycerin
Glossy ganoderma spore oil 90 parts
1 part of calendula essential oil.
The skin cream prepared by the formula is smeared on the skin, and then the moisturizing effect and the wound healing degree are measured.
Example 2
An infant skin cream formula of ganoderma lucidum spore oil comprises the following raw materials in parts by weight;
2500 parts of tea tree fruit oil
1800 portions of beeswax
100 parts of Qiongya plum-leaf crab oil
200 portions of glycerol
100 portions of ganoderma lucidum spore oil
2 parts of calendula essential oil.
The skin cream prepared by the formula is smeared on the skin, and then the moisturizing effect and the wound healing degree are measured.
Example 3
An infant skin cream formula of ganoderma lucidum spore oil comprises the following raw materials in parts by weight;
1490 portion and 2510 portion of tea tree fruit oil
1790 portion of beeswax and 1810 portion
90-110 parts of malus micromalus oil
Glycerin 190-
90-110 parts of ganoderma lucidum spore oil
1-3 parts of calendula essential oil.
The skin cream prepared by the formula is smeared on the skin, and then the moisturizing effect and the wound healing degree are measured.
The moisture retention test data and wound healing test data are shown in table 1;
TABLE 1
| Water content | Extent of healing | |
| Example 1 | 85％ | 25％ |
| Example 2 | 90％ | 31％ |
| Example 3 | 87％ | 21％ |
It can be seen from examples 1-3 that the skin cream of the formulation of example 2 can effectively moisturize the skin, maintain the skin in a moisturized state, and simultaneously promote wound healing.
Referring to fig. 1, a process for preparing ganoderma lucidum spore oil skin cream for infants and adults is characterized in that; the preparation process is used for preparing the formula of the ganoderma lucidum spore oil skin cream for infants and adults in claim 1: the preparation process comprises the following steps;
s1: 2500 parts of tea tree fruit oil with the purity of more than 99 percent, 1800 parts of beeswax, 100 parts of malus micromalus oil and 200 parts of glycerol are purchased;
s2: placing 2500 parts of tea tree fruit oil prepared in S1, 1800 parts of beeswax, 100 parts of malus wallichiana oil and 200 parts of glycerol into a sterile container, heating in a water bath at 75-85 ℃ in a water bath, and uniformly stirring and mixing by using a glass rod in the heating and dissolving process;
s3: purchasing 100 parts of ganoderma lucidum spore oil with the purity of more than 99% and 2 parts of calendula essential oil;
s4: standing the mixture stirred and dissolved in the step S2, adding 100 parts of ganoderma lucidum spore oil and 2 parts of calendula essential oil when the temperature of the surface and the temperature of the interior of the mixture reach 60 ℃ through a temperature measuring gun, and fully stirring and uniformly mixing through a glass rod;
s5: and filling the uniformly mixed raw materials into a paste filling machine, keeping the constant temperature at 60 ℃, and filling the paste in an aseptic manner.
And in the S1, the tea tree fruit oil, the beeswax, the malus micromalus oil and the glycerin are purchased through an online purchase mode, and an official store is selected for purchase.
The sterile container in S2 is sterilized by radiation sterilization and alcohol before use.
In the step S3, the ganoderma lucidum spore oil and the calendula essential oil are purchased through an online shopping mode, and official stores are selected for purchase.
And S4, when the temperature is reduced, continuously stirring by using the glass rod and intermittently measuring whether the temperature is reduced to 60 ℃.
And spraying a code on the surface of the finished product subjected to the S5 filling after alcohol sterilization to obtain the production date and the shelf life.
The glass rod in S2 was sterilized by radiation sterilization and alcohol before use and then used.
The application method comprises taking out appropriate amount of skin ointment, uniformly applying onto skin surface, cleaning skin before sleep, washing off excessive skin ointment, and re-applying appropriate amount of skin ointment.
In the description herein, references to the description of "one embodiment," "an example," "a specific example" or the like are intended to mean that a particular feature, structure, material, or characteristic described in connection with the embodiment or example is included in at least one embodiment or example of the invention. In this specification, the schematic representations of the terms used above do not necessarily refer to the same embodiment or example. Furthermore, the particular features, structures, materials, or characteristics described may be combined in any suitable manner in any one or more embodiments or examples.
The foregoing shows and describes the general principles, essential features, and advantages of the invention. It will be understood by those skilled in the art that the present invention is not limited to the embodiments described above, which are described in the specification and illustrated only to illustrate the principle of the present invention, but that various changes and modifications may be made therein without departing from the spirit and scope of the present invention, which fall within the scope of the invention as claimed.
Claims (8)
1. The formula of the ganoderma lucidum spore oil skin cream for infants and adults is characterized in that: the ganoderma lucidum spore oil skin cream for infants and adults consists of the following raw materials in parts by weight;
1490 portion and 2510 portion of tea tree fruit oil
1790 portion of beeswax and 1810 portion
90-110 parts of malus micromalus oil
Glycerin 190-
90-110 parts of ganoderma lucidum spore oil
1-3 parts of calendula essential oil.
2. A preparation process of ganoderma spore oil skin cream for infants and adults is characterized in that; the preparation process is used for preparing the formula of the ganoderma lucidum spore oil skin cream for infants and adults in claim 1: the preparation process comprises the following steps;
s1: 2500 parts of tea tree fruit oil with the purity of more than 99 percent, 1800 parts of beeswax, 100 parts of malus micromalus oil and 200 parts of glycerol are purchased;
s2: placing 2500 parts of tea tree fruit oil prepared in S1, 1800 parts of beeswax, 100 parts of malus wallichiana oil and 200 parts of glycerol into a sterile container, heating in a water bath at 75-85 ℃ in a water bath, and uniformly stirring and mixing by using a glass rod in the heating and dissolving process;
s3: purchasing 100 parts of ganoderma lucidum spore oil with the purity of more than 99% and 2 parts of calendula essential oil;
s4: standing the mixture stirred and dissolved in the step S2, adding 100 parts of ganoderma lucidum spore oil and 2 parts of calendula essential oil when the temperature of the surface and the temperature of the interior of the mixture reach 60 ℃ through a temperature measuring gun, and fully stirring and uniformly mixing through a glass rod;
s5: and filling the uniformly mixed raw materials into a paste filling machine, keeping the constant temperature at 60 ℃, and filling the paste in an aseptic manner.
3. The preparation process of the ganoderma lucidum spore oil skin cream for infants and adults according to claim 2, which is characterized by comprising the following steps of: and in the S1, the tea tree fruit oil, the beeswax, the malus micromalus oil and the glycerin are purchased through an online purchase mode, and an official store is selected for purchase.
4. The preparation process of the ganoderma lucidum spore oil skin cream for infants and adults according to claim 3, which is characterized by comprising the following steps of: the sterile container in S2 is sterilized by radiation sterilization and alcohol before use.
5. The preparation process of the ganoderma lucidum spore oil skin cream for infants and adults according to claim 4, which is characterized by comprising the following steps of: in the step S3, the ganoderma lucidum spore oil and the calendula essential oil are purchased through an online shopping mode, and official stores are selected for purchase.
6. The preparation process of the ganoderma lucidum spore oil skin cream for infants and adults according to claim 5, which is characterized by comprising the following steps of: and S4, when the temperature is reduced, continuously stirring by using the glass rod and intermittently measuring whether the temperature is reduced to 60 ℃.
7. The preparation process of the ganoderma lucidum spore oil skin cream for infants and adults according to claim 6, which is characterized by comprising the following steps of: and spraying a code on the surface of the finished product subjected to the S5 filling after alcohol sterilization to obtain the production date and the shelf life.
8. The preparation process of the ganoderma lucidum spore oil skin cream for infants and adults according to claim 7, which is characterized by comprising the following steps of: the glass rod in S2 was sterilized by radiation sterilization and alcohol before use and then used.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111395537.9A CN114053173A (en) | 2021-11-23 | 2021-11-23 | Formula and preparation process of ganoderma lucidum spore oil skin cream for infants and adults |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111395537.9A CN114053173A (en) | 2021-11-23 | 2021-11-23 | Formula and preparation process of ganoderma lucidum spore oil skin cream for infants and adults |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN114053173A true CN114053173A (en) | 2022-02-18 |
Family
ID=80275441
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111395537.9A Pending CN114053173A (en) | 2021-11-23 | 2021-11-23 | Formula and preparation process of ganoderma lucidum spore oil skin cream for infants and adults |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114053173A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007134548A1 (en) * | 2006-05-24 | 2007-11-29 | Guangdong Yuewei Edible Fungi Technology Co. Ltd | A process for preparing ganoderma spore oil |
| CN109077955A (en) * | 2018-09-14 | 2018-12-25 | 中农美生(天津)生物科技有限责任公司 | A kind of compounding method of the lucidum spore powder for cosmetics |
-
2021
- 2021-11-23 CN CN202111395537.9A patent/CN114053173A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007134548A1 (en) * | 2006-05-24 | 2007-11-29 | Guangdong Yuewei Edible Fungi Technology Co. Ltd | A process for preparing ganoderma spore oil |
| CN109077955A (en) * | 2018-09-14 | 2018-12-25 | 中农美生(天津)生物科技有限责任公司 | A kind of compounding method of the lucidum spore powder for cosmetics |
Non-Patent Citations (1)
| Title |
|---|
| 丁梦祥等: "灵芝孢子油制备护手霜工艺研究" * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN109125107B (en) | Polypeptide composition for effectively improving and repairing facial hormone-dependent dermatitis | |
| Pounikar et al. | Formulation and characterization of Aloe vera cosmetic herbal hydrogel | |
| CN108524374A (en) | It is a kind of for the toothpaste and its manufacturing method of a variety of oral problems and application | |
| CN102266280B (en) | Application of refined deer oil to preparation of moisture preserving cosmetics | |
| CN106619186A (en) | Preparation for protecting activity of superoxide dismutase (SOD) and preparation method of preparation | |
| CN110833519A (en) | Soothing and moisturizing mask liquid containing industrial hemp leaf extract and preparation method thereof | |
| CN107412255A (en) | Skin barrier remediation composition and preparation | |
| CN109512712A (en) | A kind of toner and preparation method thereof | |
| CN114053173A (en) | Formula and preparation process of ganoderma lucidum spore oil skin cream for infants and adults | |
| CN107519118A (en) | A kind of snake gall eye mask and preparation method thereof | |
| CN111568781A (en) | Skin care gel and preparation method thereof | |
| CN103006477A (en) | Camellia oil emollient cream | |
| CN115919686A (en) | Skin soothing lotion for enhancing skin barrier and preparation method thereof | |
| JP2015086160A (en) | Moisturizing agent, rough and dry skin improving agent, horny layer moisture content increasing agent, blood flow improving agent, and improving agent of skin dullness, dark circles, or gloss | |
| CN108236715A (en) | Whitening antibacterial gel and its manufacture craft are repaired in a kind of female private part, vagina moisturizing | |
| CN112370404B (en) | Moisturizing and whitening composition, and preparation method and application thereof | |
| CN109745241B (en) | Poria cocos mask liquid and preparation method thereof | |
| CN114469811A (en) | Collagen anti-wrinkle repair mask and production process | |
| CN107375012A (en) | A kind of skin barrier remediation composition and preparation | |
| CN111388375A (en) | Skin-tightening and anti-aging stock solution skin care product | |
| CN107375142B (en) | A kind of preparation method of Chinese medicine beauty antiwrinkle cream | |
| CN108451809A (en) | A kind of Chinese medicine skin rejuvenating facial mask and its processing technology | |
| CN102920634A (en) | Moderate liquid cosmetic with effects of radioresistance and skin moisture improvement | |
| CN108815018A (en) | A kind of castor rat-tail muscle extracts the facial mask liquid and preparation method thereof of collagen peptide | |
| KR102637766B1 (en) | Biodegradable film for improving skin function and method for preparing thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220218 |
|
| RJ01 | Rejection of invention patent application after publication |